Outline I have trouble working with ODBs

Slides:



Advertisements
Similar presentations
AnCompany.... Monitoring New Drugs for Safety in Insurance Claims Alexander M. Walker Sr VP Epidemiology I3 Magnifi.
Advertisements

Area 4 SHARP Face-to-Face Conference Phenotyping Team – Centerphase Project Assessing the Value of Phenotyping Algorithms June 30, 2011.
Some comments on the 3 papers Robert T. O’Neill Ph.D.
CUMC IRB Investigator Meeting November 9, 2004 Research Use of Stored Data and Tissues.
By Dr. Ahmed Mostafa Assist. Prof. of anesthesia & I.C.U. Evidence-based medicine.
Principles of New Animal Drug Effectiveness: An Overview
Cohort Studies Hanna E. Bloomfield, MD, MPH Professor of Medicine Associate Chief of Staff, Research Minneapolis VA Medical Center.
CLIA COMPLIANCE. What is CLIA? In 1988 Congress turned its attention to deficiencies in the quality of services provided by the nation’s laboratories.
Patient Safety Initiatives Kelly Cronin Director, Patient Safety and Outcomes Research Office of Policy and Planning Office of the Commissioner FDA.
Interoperability to Support a Learning Health System HL7 Learning Health Systems Workgroup.
What research is Noun: The systematic investigation into and study of materials and sources in order to establish facts and reach new conclusions. Verb:
Research Design. Research is based on Scientific Method Propose a hypothesis that is testable Objective observations are collected Results are analyzed.
دکتر خلیلی 1. Lucid the way to “ Research” And Follow an “ Evidence Based Medicine”
Consumer behavior studies1 CONSUMER BEHAVIOR STUDIES STATISTICAL ISSUES Ralph B. D’Agostino, Sr. Boston University Harvard Clinical Research Institute.
Division of Population Health Sciences Royal College of Surgeons in Ireland Coláiste Ríoga na Máinleá in Éirinn Connected health: collaborative opportunities.
Click to edit Master title style Health Information Technology: Driving Improvements in Medicaid Don Imholz Executive Vice President and Chief Information.
Kevin W. Ryan JD, MA Associate Director – ACHI Assistant Professor – UAMS COPH Rural TeleCon ’06 10th Annual Conference of the Rural Telecommunications.
FDA Risk Management Workshop – Day #3 April 11, 2003 Robert C. Nelson, Ph.D. RCN Associates, Inc Annapolis, MD, USA.
Collaborating With Your Health Plan 03/07/05 To paraphrase A. Einstein: We cannot solve today’s problems with the same level of thinking that created them.
Levels of Review of Research and Quality Improvement Walter Kraft, MD Associate Director, Office of Human Subjects Protection Department of Pharmacology.
1 Administrative Simplification: The Last Word National HIPAA Summit 8 Baltimore, MD March 9, 2004 William R. Braithwaite, MD, PhD “Doctor HIPAA”
Uses of the NIH Collaboratory Distributed Research Network Jeffrey Brown, PhD for the DRN Team Harvard Pilgrim Health Care Institute and Harvard Medical.
Health Management Information Systems Unit 3 Electronic Health Records Component 6/Unit31 Health IT Workforce Curriculum Version 1.0/Fall 2010.
PRAGMATIC Study Designs: Elderly Cancer Trials
Intersecting roles CMS and FDA – implications for pharmaceutical and device industries Peter B. Bach, MD, MAPP Senior Adviser, Office of the Administrator.
Clinical Trials for Comparative Effectiveness Research Mark Hlatky MD Mark Hlatky MD Stanford University January 10, 2012.
Research Activities at The Boston Collaborative Drug Surveillance Program; Boston University School of Public Health Susan Jick Professor of Epidemiology.
A Genomics-Enabled Rapid Learning Health System Goals for 2015 & 2016 Lynn Etheredge IOM – December 8, 2014.
European Patients’ Academy on Therapeutic Innovation Challenges in Personalised Medicine.
HCA 497 MART Experience Tradition /hca497mart.com FOR MORE CLASSES VISIT
Tim Friede Department of Medical Statistics
Study Design: Making research pretty Adam P. Sima, PhD July 13, 2016
Logic Models How to Integrate Data Collection into your Everyday Work.
BIAS AND CONFOUNDING Nigel Paneth.
ICD-10 Updates & review.
The Pennsylvania state university college of nursing Nursing 200w
Documentation and Medical Records
Susan Sonne, PharmD, BCPP Chair, MUSC IRB II
DATA COLLECTION METHODS IN NURSING RESEARCH
Using internet information critically Reading papers Presenting papers
Evidence-based Medicine
Patrick Ryan, PhD Janssen Research and Development
The Information Professional’s Role in Product Safety
Donald E. Cutlip, MD Beth Israel Deaconess Medical Center
Reaching Goals and Objectives
Federal Health IT Ontology Project (HITOP) Group
Randomized Trials: A Brief Overview
BIAS AND CONFOUNDING
Architecture-Specific Considerations and Methods for Data Quality Assessment in Collaborative Clinical Data Research Networks Chunhua Weng, PhD Associate.
How do we improve the “sufficiency” of the FDA’s Sentinel System?
Water Quality Monitoring -Sampling Design-
H676 Meta-Analysis Brian Flay WEEK 1 Fall 2016 Thursdays 4-6:50
Nursing-Sensitive Quality Indicators And Safety Initiatives
Practical clinical chemistry
PCORTF Common Data Model Harmonization Project and the Oncology Use case January 30, 2018.
S1316 analysis details Garnet Anderson Katie Arnold
مدیریت داده ها و اطلاعات آزمایشگاه پزشکی
Pragmatic RCTs and the Learning Healthcare System
Friends of Cancer Research
Tim Auton, Astellas September 2014
ABAB Design Ethical considerations
KWL Topic: _________Scientific Method______________________________
CONCEPTS TO BE INCLUDED
FDA Sentinel Initiative
Evidence Based Practice
Unit 2 – Methods Objective 1 Describe quantitative and qualitative  methods such as surveys, polls, and statistics used in sociological research.  Objective.
Regulatory Perspective of the Use of EHRs in RCTs
Using clinical trial data as real-world evidence
eHR Clinical data repository and pharmacovigilance
CPSA 4 Corners Initiative 2018
Presentation transcript:

Outline I have trouble working with ODBs Patient  Measure  DB Input & Processing  Analyses Each step has noise and bias Patients report differently based on background characteristics Measurements a well known error and sometimes bias source DBs have structures and conventions for purposes different from the ones our queries may fit with DB input & processing (coding conventions, reimbursement policy) Analyses try to anticipate these but may make it worse

DB Input & Processing A database poorly approximates the reality that we purport it captures (given our query) because … databases arise in a larger system with rules that can be at odds with both the overt reason for its existence and the question we want to answer people alter inputs to counter the larger system (say hosptital or payer) rules so they can get their work done chronological trends such as changes in reimbursement policies or, in the case of drugs, prescribing rules

Why worry? Analyses will fix it! Stakeholders may care: patients, providers, regulators … Many observational database studies (ODS) published each day Safety of a drug requires knowledge gained from multiple sources Electronic health records (EHR), claims data, and spontaneous report systems (SRS) provide sources beyond clinical trials (CT/RCT) – with >>> N’s

Besides, RCTs are overated, and unable to answer questions of sample size or ethical sensitivity https://www.sciencedirect.com/journal/social-science-and-medicine/vol/210/suppl/C

Level of problem Simulation work by Franklin et al (2014) drug studies in claims data may suffer from bias due to residual confounding (Brookhart et al 2010) Methods for adjustment need testing Covariates can help to a point

Exploring EHRs in their own right Hripcsak & Albers (2013) Propose studying EHRs as a subject unto itself Review of data collection protocols Testing of new methods to correct data Step one – harmonize at a basic level

OHDSI: OMOP common data model To allow the systematic analysis of disparate observational databases Transform data contained within various databases into a common format (data model) Use common representation for terminologies, vocabularies, coding schemes Additionally have a library of standard analytic routines that have been written based on the common format for systematic analyses of the combined data

Sentinel Establishment of the Sentinel Operations Center Sentinel’s Major Accomplishments (from https://www.sentinelinitiative.org/background) Establishment of the Sentinel Operations Center Creation of a common data model and distributed data approach that enables FDA to monitor the performance of medical products while securing and safeguarding patient privacy Development of a distributed database with more than 300 million person-years of high quality, unduplicated, curated data

Sentinel Development of processes for turning FDA’s safety concerns into queries of the Sentinel distributed data that can be responded to rapidly by Data Partners, often within weeks, in support of FDA’s regulatory needs Substantial progress toward development of a mature data analytics system Recruitment of a broad group of scientific collaborators who regularly provide the FDA with valuable technical support in evaluating electronic health data

Sentinel Development of focused surveillance efforts around vaccine safety with the Postmarket Rapid Immunization Safety Monitoring (PRISM) system and around blood and blood products with the Blood Surveillance Continuous Active Network (BloodSCAN)

Some other initiatives http://www.stratos-initiative.org/ Focus on design and analysis https://pcornet.org/ Has a common data model Network of data sources Appears many other individuals and groups focus on some of these problems, but not clear how many go into policy and initial database purpose issues

Levels of harmony 1) data are in the same form and coding 2) policies are the same 3) patients and HCPs act similarly Next example has 1 and maybe 2

Obvious test interpretations? Agneil et al Two hospital EHR systems Use 272 common lab tests’ data to predict survival in ~670000 treated patients over 1 year Compare predictive ability of actual test lab value versus the time of the day, day of the week, and ordering frequency of the test

Not obvious lab test interpretations “The presence of a laboratory test order, regardless of any other information about the test result, has a significant association (P<0.001) with the odds of survival in 233 of 272 (86%) tests. Data about the timing of when laboratory tests were ordered were more accurate than the test results in predicting survival in 118 of 174 tests (68%).”

How bad can biases get? Illinois Wellness Study Population – employees in the UI system Methods – randomized to get invited to “wellness” program or not Health outcomes followed for a year (and more) Analyzed two ways – based on randomization and using an observational subgroup

How bad can biases get? Randomized study analyses found no effect of program on health outcome one year after initiation When analyzed using only the “observational” cohort, results favored the wellness program

example in my work Coding Processing Interpretation Automation

Back to things to try Hripcsak & Albers (2013) Propose studying EHRs as a subject unto itself Review of data collection protocols Testing of new methods to correct data